Clarithromycin, a semisynthetic macrolide antibiotic derived from erythromycin, inhibits bacterial protein synthesis by binding to the bacterial 50S ribosomal subunit.
This report contains market size and forecasts of Clarithromycin Tablets in global, including the following market information:
Global Clarithromycin Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Clarithromycin Tablets Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Clarithromycin Tablets companies in 2021 (%)
The global Clarithromycin Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
250 mg Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clarithromycin Tablets include Abbvie, Abbott, Mylan, Apotex, Sandoz, Takeda Pharmaceuticals, Teva Pharmaceutical, Sun Pharmaceutical and Aurobindo Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Clarithromycin Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clarithromycin Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Clarithromycin Tablets Market Segment Percentages, by Type, 2021 (%)
250 mg Tablets
500 mg Tablets
Global Clarithromycin Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Clarithromycin Tablets Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Clarithromycin Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Clarithromycin Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clarithromycin Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Clarithromycin Tablets revenues share in global market, 2021 (%)
Key companies Clarithromycin Tablets sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Clarithromycin Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie
Abbott
Mylan
Apotex
Sandoz
Takeda Pharmaceuticals
Teva Pharmaceutical
Sun Pharmaceutical
Aurobindo Pharma
Mayne Pharma
Jiangsu Hengrui Medicine